GRIFOLS | GRF - Assets


GRIFOLS reported EUR20.09B in Assets for its fiscal quarter ending in June of 2026.





Assets Change Date
Alcon AG USD 31.62B 64M Mar/2026
Almirall EUR 2.37B 29.97M Jun/2026
Amadeus IT EUR 11.76B 332.2M Jun/2026
Amarin USD 624.36M 21.4M Jun/2026
argenx SE USD 10.03B 1.35B Jun/2026
AstraZeneca USD 115.83B 1.82B Jun/2026
Bayer EUR 107.94B 3.4B Mar/2026
Cie Automotive EUR 5.68B 97.53M Dec/2025
Demant DKK 39.07B 6.43B Dec/2025
Ence Energia y Celulosa EUR 1.65B 9.23M Mar/2026
Essilor EUR 65.06B 1.16B Jun/2026
Ferrovial EUR 27.22B 201M Jun/2026
Fresenius EUR 42.37B 975M Mar/2026
Fresenius Medical Care EUR 31.47B 465.26M Mar/2026
Genmab DKK 12.87B 5.85B Dec/2025
GlaxoSmithKline GBP 61.74B 1.13B Jun/2026
GRIFOLS EUR 20.09B 12M Jun/2026
Hikma Pharmaceutical USD 5.67B 117M Dec/2025
Inditex EUR 36.49B 851M Mar/2026
Lakefront Biotherapeutics EUR 3.37B 34.09M Mar/2026
Merck EUR 53.07B 1.54B Mar/2026
Novartis USD 122.03B 3.5B Jun/2026
Philips EUR 26.7B 565M Jun/2026
Roche Holding CHF 98.2B 2.5B Jun/2026
Sanofi EUR 129.06B 1.04B Jun/2026
Smith & Nephew USD 11.01B 321M Jun/2026
UCB EUR 18.16B 971M Dec/2025
Viscofan EUR 1.53B 12.29M Jun/2026